Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2–17 years: a randomised, placebo-controlled, phase 2 trial

1. Tricou, V.
2. Sáez-Llorens, X.
3. Yu, D.
4. Rivera, L.
5. Jimeno, J.
6. Villarreal, A.C.
7. Dato, E.
8. Saldaña de Suman, O.
9. Montenegro, N.
10. DeAntonio, R.
11. Mazara, S.
12. Vargas, M.
13. Mendoza, D.
14. Rauscher, M.
15. Brose, M.
16. Lefevre, I.
17. Tuboi, S.
18. Borkowski, A.
19. Wallace, D.